Translating cell therapy manufacturing
Will integrated automation transform speed and efficiency for cell therapy products while minimizing risk?
Cell and gene therapies are revolutionizing healthcare by saving lives — like Emily’s. What made that possible? Passion and dedication from patients, families, scientists, and doctors. What we need now is more standardized and reproducible processes for making these therapies. That’s where Cytiva comes in.
Will integrated automation transform speed and efficiency for cell therapy products while minimizing risk?
When your mRNA process challenges start to feel out of control, we'll help you find firm ground.
Cytiva continues to navigate the changes and innovations in oligonucleotides and genetic editing.
We bring together insights to help you develop a scalable and cost-efficient manufacturing process.
How reliable lipid nanoparticle (LNP) production will help move promising nucleic acid candidates to market.
Keys to success for oligonucleotide medicinal products.
What’s next for mRNA? The future looks bright ― just ask this team of pioneers and visionaries.
Improving human health with biotechnology while protecting the planet.